ABO blood group and von Willebrand factor: biological implications

被引：46
作者：
Franchini, Massimo [1 ]
Crestani, Silvia [1 ]
Frattini, Francesco [1 ]
Sissa, Cinzia [1 ]
Bonfanti, Carlo [1 ]
机构：
[1] Azienda Osped Carlo Poma, Dipartimento Med Trasfus & Ematol, Mantua, Italy
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2014年 / 52卷 / 09期
关键词：
ABO; ADAMTS13; desmopressin; LRP1; von Willebrand disease; von Willebrand factor; N-LINKED GLYCOSYLATION; GENETIC RISK-FACTOR; FACTOR-VIII; ADAMTS13; PROTEOLYSIS; VASCULAR-DISEASE; HALF-LIFE; IN-VIVO; CLEARANCE; PHENOTYPE; COHORT;
D O I：
10.1515/cclm-2014-0564
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
ABO blood group antigens are complex carbohydrate molecules expressed on the surface of red blood cells and a variety of human cells and tissues. It is well known that ABO blood type exerts a profound influence on hemostasis, being a major determinant of von Willebrand factor (VWF), and consequently factor VIII, plasma levels. In this review, we will focus on the molecular mechanisms underlying the interaction between ABO blood group and VWF in normal and pathological conditions.
引用
收藏
页码：1273 / 1276
页数：4
相关论文
共 37 条
[21]   Beyond immunohaematology: the role of the ABO blood group in human diseases [J].
Liumbruno, Giancarlo Maria ;
Franchini, Massimo .
BLOOD TRANSFUSION, 2013, 11 (04) :491-499
[22]   Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis [J].
McGrath, Rachel T. ;
van den Biggelaar, Maartje ;
Byrne, Barry ;
O'Sullivan, Jamie M. ;
Rawley, Orla ;
O'Kennedy, Richard ;
Voorberg, Jan ;
Preston, Roger J. S. ;
O'Donnell, James S. .
BLOOD, 2013, 122 (25) :4107-4110
[23]   Expression of terminal α2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13 [J].
McGrath, Rachel T. ;
McKinnon, Thomas A. J. ;
Byrne, Barry ;
O'Kennedy, Richard ;
Terraube, Virginie ;
McRae, Emily ;
Preston, Roger J. S. ;
Laffan, Mike A. ;
O'Donnell, James S. .
BLOOD, 2010, 115 (13) :2666-2673
[24]   Platelet von Willebrand factor - structure, function and biological importance [J].
McGrath, Rachel T. ;
McRae, Emily ;
Smith, Owen P. ;
O'Donnell, James S. .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (06) :834-843
[25]   N-linked glycosylation of VWF modulates its interaction with ADAMTS13 [J].
McKinnon, Thomas A. J. ;
Chion, Alain C. K. ;
Millington, Alexander J. ;
Lane, David A. ;
Laffan, Mike A. .
BLOOD, 2008, 111 (06) :3042-3049
[26]   Specific N-linked glycosylation sites modulate synthesis and secretion of von Willebrand factor [J].
McKinnon, Thomas A. J. ;
Goode, Elizabeth C. ;
Birdsey, Graeme M. ;
Nowak, Agata A. ;
Chan, Alain C. K. ;
Lane, David A. ;
Laffan, Michael A. .
BLOOD, 2010, 116 (04) :640-648
[27]   Survival of von Willebrand factor released following DDAVP in a type I von Willebrand disease cohort: Influence of glycosylation, proteolysis and gene mutations [J].
Millar, Carolyn M. ;
Riddell, Anne F. ;
Brown, Simon A. ;
Starke, Richard ;
Mackie, Ian ;
Bowen, Derrick J. ;
Jenkins, P. Vincent ;
van Mourik, Jan A. .
THROMBOSIS AND HAEMOSTASIS, 2008, 99 (05) :916-924
[28]   Influence of ABO blood groups on primary hemostasis [J].
Moeller, A ;
Weippert-Kretschmer, M ;
Prinz, H ;
Kretschmer, V .
TRANSFUSION, 2001, 41 (01) :56-60
[29]   The relationship between ABO histo-blood group, factor VIII and von Willebrand factor [J].
O'Donnell, J ;
Laffan, MA .
TRANSFUSION MEDICINE, 2001, 11 (04) :343-351
[30]   Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis [J].
O'Donnell, JS ;
McKinnon, TAJ ;
Crawley, JTB ;
Lane, DA ;
Laffan, MA .
BLOOD, 2005, 106 (06) :1988-1991
1234